Clinical Trial Update: Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100 [NA]

View source ↗

Summary

Clinical trial update for a repeat insult patch test protocol addressing allergic sensitization; study status completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Sensitization

Drugs mentioned

• Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.

Snippet

Sponsor: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. | Conditions: Allergic Sensitization | NA | Status: COMPLETED | Results posted: 2019-04-03